Interleukin-6 deletion in mice driven by aP2-Cre-ERT2 prevents against high-fat diet-induced gain weight and adiposity in female mice

Acta Physiologica

Volumn 211, Issue 4, 2014, Pages 585-596

  Navia, B ^a   Ferrer, B ^b   Giralt, M ^b   Comes, G ^b   Carrasco, J ^b   Molinero, A ^b   Quintana, A ^b,f   Leclerc, J ^c,d,e   Viollet, B ^c,d,e   Senaris R M ^a   Hidalgo, J ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b INSTITUT DE NEUROCIÈNCIES   (Spain)

^c INSERM   (France)

^d INSTITUT COCHIN   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

AP2 Cre induced IL 6 deficiency; Body weight; High fat diet; Hypothalamic factors; Insulin signalling

Indexed keywords

AGOUTI RELATED PEPTIDE; CHOLESTEROL; CORTICOTROPIN RELEASING FACTOR; CRE RECOMBINASE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN PROMOTER CRE INDUCIBLE SYSTEM; FATTY ACID SYNTHASE; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; NEUROPEPTIDE Y; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROOPIOMELANOCORTIN; PROTEIN; PROTEIN KINASE B; PROTIRELIN; STAT3 PROTEIN; TAMOXIFEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FABP4 PROTEIN, MOUSE; INTERLEUKIN-6, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENERGY EXPENDITURE; ENZYME PHOSPHORYLATION; FATTY LIVER; FEMALE; GENE DELETION; GENE EXPRESSION; GENOTYPE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STUDY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; WEIGHT GAIN; WILD TYPE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; GENETICS; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOSITY; ANIMALS; DIET, HIGH-FAT; FATTY ACID-BINDING PROTEINS; FEMALE; IN SITU HYBRIDIZATION; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; WEIGHT GAIN;

EID: 84904255928     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12328     Document Type: Article

References (59)

1. Abramoff, M.D., Magelhaes, P.J. & Ram, S.J. 2004. Image processing with ImageJ. Biophotonics Int 11, 36-42.
2. Adser, H., Wojtaszewski, J.F., Jakobsen, A.H., Kiilerich, K., Hidalgo, J. & Pilegaard, H. 2011. Interleukin-6 modifies mRNA expression in mouse skeletal muscle. Acta Physiol 202, 165-173.
3. Allen, T.L. & Febbraio, M.A. 2010. IL6 as a mediator of insulin resistance: fat or fiction? Diabetologia 53, 399-402.
4. Antonson, P., Matic, M., Portwood, N., Kuiper, R.V., Bryzgalova, G., Gao, H., Windahl, S.H., Humire, P., Ohlsson, C., Berggren, P.O., Gustafsson, J.Å. & Dahlman-Wright, K. 2014. aP2-Cre-mediated inactivation of estrogen receptor alpha causes hydrometra. PLoS One 9, e85581.
5. Bastard, J.P., Jardel, C., Bruckert, E., Blondy, P., Capeau, J., Laville, M., Vidal, H. & Hainque, B. 2000. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85, 3338-3342.
6. Bastard, J.P., Maachi, M., Van Nhieu, J.T., Jardel, C., Bruckert, E., Grimaldi, A., Robert, J.J., Capeau, J. & Hainque, B. 2002. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87, 2084-2089.
7. Benrick, A., Schéle, E., Pinnock, S.B., Wernstedt-Asterholm, I., Dickson, S.L., Karlsson-Lindahl, L. & Jansson, J.O. 2009. Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei. J Neuroendocrinol 21, 620-628.
8. Cernkovich, E.R., Deng, J., Bond, M.C., Combs, T.P. & Harp, J.B. 2008. Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 149, 1581-1590.
9. Coll, A.P., Farooqi, I.S. & O'Rahilly, S. 2007. The hormonal control of food intake. Cell 129, 251-262.
10. De Souza, C.T., Araujo, E.P., Bordin, S., Ashimine, R., Zollner, R.L., Boschero, A.C., Saad, M.J. & Velloso, L.A. 2005. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192-4199.
11. Di Gregorio, G.B., Hensley, L., Lu, T., Ranganathan, G. & Kern, P.A. 2004. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab 287, E182-E187.
12. Ellacott, K.L., Morton, G.J., Woods, S.C., Tso, P. & Schwartz, M.W. 2010. Assessment of feeding behavior in laboratory mice. Cell Metab 12, 10-17.
13. Ellingsgaard, H., Ehses, J.A., Hammar, E.B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D., Halban, P.A., Schuit, F.C. & Donath, M.Y. 2008. Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc Natl Acad Sci USA 105, 13163-13168.
14. Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A.M., Baggio, L.L., Meier, D.T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y.D. et al. 2011. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17, 1481-1489.
15. Enriori, P.J., Evans, A.E., Sinnayah, P., Jobst, E.E., Tonelli-Lemos, L., Billes, S.K., Glavas, M.M., Grayson, B.E., Perello, M., Nillni, E.A., Grove, K.L. & Cowley, M.A. 2007. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab 5, 181-194.
16. Erta, M., Quintana, A. & Hidalgo, J. 2012. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8, 1254-1266.
17. Fain, J.N., Madan, A.K., Hiler, M.L., Cheema, P. & Bahouth, S.W. 2004. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273-2282.
18. Ferrer, B., Navia, B., Giralt, M., Comes, G., Carrasco, J., Molinero, A., Quintana, A., Señarís, R.M. & Hidalgo, J. 2014. Muscle-specific interleukin-6 deletion influences body weight and body fat in a sex-dependent manner. Brain Behav Immun. Doi: 10.1016/j.bbi.2014.03.001. in press.
19. Fève, B. & Bastard, J.P. 2009. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 5, 305-311.
20. Franckhauser, S., Elias, I., Rotter Sopasakis, V., Ferré, T., Nagaev, I., Andersson, C.X., Agudo, J., Ruberte, J., Bosch, F. & Smith, U. 2008. Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia 51, 1306-1316.
21. Glund, S. & Krook, A. 2008. Role of interleukin-6 signalling in glucose and lipid metabolism. Acta Physiol (Oxf) 192, 37-48.
22. Gregor, M.F. & Hotamisligil, G.S. 2011. Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445.
23. van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Møller, K., Saltin, B., Febbraio, M.A. & Pedersen, B.K. 2003. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88, 3005-3010.
24. Hidalgo, J., Florit, S., Giralt, M., Ferrer, B., Keller, C. & Pilegaard, H. 2010. Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat. Brain Behav Immun 24, 119-261.
25. Hiscock, N., Chan, M.H., Bisucci, T., Darby, I.A. & Febbraio, M.A. 2004. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J 18, 992-994.
26. Imai, T., Jiang, M., Chambon, P. & Metzger, D. 2001. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc Natl Acad Sci USA 98, 224-228.
27. Inoue, H., Ogawa, W., Ozaki, M., Haga, S., Matsumoto, M., Furukawa, K., Hashimoto, N., Kido, Y., Mori, T., Sakaue, H. et al. 2004. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 10, 168-174.
28. Kasuga, M. 2006. Insulin resistance and pancreatic beta cell failure. J Clin Invest 116, 1756-1760.
29. Kishimoto, T., Akira, S., Narazaki, M. & Taga, T. 1995. Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254.
30. Klover, P.J., Zimmers, T.A., Koniaris, L.G. & Mooney, R.A. 2003. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52, 2784-2789.
31. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. & Köhler, G. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342.
32. Lee, K.Y., Russell, S.J., Ussar, S., Boucher, J., Vernochet, C., Mori, M.A., Smyth, G., Rourk, M., Cederquist, C., Rosen, E.D., Kahn, B.B. & Kahn, C.R. 2013. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes 62, 864-874.
33. Li, G., Klein, R.L., Matheny, M., King, M.A., Meyer, E.M. & Scarpace, P.J. 2002. Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats. Neuroscience 115, 879-889.
34. Lin, J., Handschin, C. & Spiegelman, B.M. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1, 361-370.
35. Martens, K., Bottelbergs, A. & Baes, M. 2010. Ectopic recombination in the central and peripheral nervous system by aP2/FABP4-Cre mice: implications for metabolism research. FEBS Lett 584, 1054-1058.
36. Matthews, V.B., Allen, T.L., Risis, S., Chan, M.H., Henstridge, D.C., Watson, N., Zaffino, L.A., Babb, J.R., Boon, J., Meikle, P.J., Jowett, J.B., Watt, M.J., Jansson, J.O., Bruce, C.R. & Febbraio, M.A. 2010. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 53, 2431-2441.
37. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D.R., Miles, J.M., Yudkin, J.S., Klein, S. & Coppack, S.W. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82, 4196-4200.
38. Mooney, R.A. 2007. Counterpoint: interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 102, 816-818.
39. Mullican, S.E., Tomaru, T., Gaddis, C.A., Peed, L.C., Sundaram, A. & Lazar, M.A. 2013. A novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods. Mol Endocrinol 27, 127-134.
40. Pan, W. & Kastin, A.J. 2007. Adipokines and the blood-brain barrier. Peptides 28, 1317-1330.
41. Pazos, P., Lima, L., Casanueva, F.F., Diéguez, C. & García, M.C. 2013. Interleukin 6 deficiency modulates the hypothalamic expression of energy balance regulating peptides during pregnancy in mice. PLoS One 8, e72339.
42. Pedersen, B.K. & Febbraio, M.A. 2007. Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 102, 814-816.
43. Persson, P.B. & Henriksson, J. 2011. Editorial. Good publication practise in physiology. Acta Physiol 203, 403-407.
44. Pettersson, U.S., Waldén, T.B., Carlsson, P.O., Jansson, L. & Phillipson, M. 2012. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One 7, e46057.
45. Quintana, A., Erta, M., Ferrer, B., Comes, G., Giralt, M. & Hidalgo, J. 2013. Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior. Brain Behav Immun 27, 162-173.
46. Rotter, V., Nagaev, I. & Smith, U. 2003. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278, 45777-45784.
47. Ruderman, N.B., Keller, C., Richard, A.M., Saha, A.K., Luo, Z., Xiang, X., Giralt, M., Ritov, V.B., Menshikova, E.V., Kelley, D.E., Hidalgo, J., Pedersen, B.K. & Kelly, M. 2006. Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes 55 (Suppl 2), S48-S54.
48. Schéle, E., Fekete, C., Egri, P., Füzesi, T., Palkovits, M., Keller, E., Liposits, Z., Gereben, B., Karlsson-Lindahl, L., Shao, R. & Jansson, J.O. 2012. Interleukin-6 receptor α is co-localised with melanin-concentrating hormone in human and mouse hypothalamus. J Neuroendocrinol 24, 930-943.
49. Schéle, E., Benrick, A., Grahnemo, L., Egecioglu, E., Anesten, F., Pálsdóttir, V. & Jansson, J.O. 2013. Interrelation between interleukin-1 (IL-1), IL-6 and body fat regulating circuits of the hypothalamic arcuate nucleus. J Neuroendocrinol 25, 580-589.
50. Señarís, R.M., Trujillo, M.L., Navia, B., Comes, G., Ferrer, B., Giralt, M. & Hidalgo, J. 2011. Interleukin-6 regulates the expression of hypothalamic neuropeptides involved in body weight in a gender-dependent way. J Neuroendocrinol 23, 675-686.
51. Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B. & Klarlund Pedersen, B. 2000. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529, 237-242.
52. Stein, B. & Yang, M.X. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 15, 4971-4979.
53. Velloso, L.A. & Schwartz, M.W. 2011. Altered hypothalamic function in diet-induced obesity. Int J Obes (Lond) 35, 1455-1465.
54. Vozarova, B., Weyer, C., Hanson, K., Tataranni, P.A., Bogardus, C. & Pratley, R.E. 2001. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9, 414-417.
55. Wallenius, K., Wallenius, V., Sunter, D., Dickson, S.L. & Jansson, J.O. 2002a. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 293, 560-565.
56. Wallenius, V., Wallenius, K., Ahren, B., Rudling, M., Carlsten, H., Dickson, S.L., Ohlsson, C. & Jansson, J.O. 2002b. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8, 75-79.
57. Wellen, K.E. & Hotamisligil, G.S. 2005. Inflammation, stress, and diabetes. J Clin Invest 115, 1111-1119.
58. Wernstedt, I., Edgley, A., Berndtsson, A., Faldt, J., Bergstrom, G., Wallenius, V. & Jansson, J.O. 2006. Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice. Am J Physiol Regul Integr Comp Physiol 291, R551-R557.
59. Zhang, X., Zhang, G., Zhang, H., Karin, M., Bai, H. & Cai, D. 2008. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61-73.